Synthesis and anticancer properties of 7α-chloro-3-methyl-1,1-dioxoceph-3-em-4-carboxylic acid esters

The tert-butyl esters of 3-azidomethyl-, 3-isocyanatomethyl-, 3-chloromethyl-, and 3-p-nitrophenylvinyl-7α-chloro-1,1-dioxoceph-3-em-4-carboxylic acid, and also esters of 7α-chloro-3-methyl-1,1-dioxoceph-3-em-4-carboxylic acid, and of 7α-chloro-3-methyl-2-dimethylaminomethylene-1,1-dioxoceph-3-em-4-carboxylic acid have been synthesized. Results of cytotoxic screening of these compounds in relation to cancer and normal cells in vitro are correlated and analyzed. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 259–273, February, 2007.     

Synthesis of 4-amino-6-chloro-1,3,5-triazin-2(1H)-ones

Conditions for selective substitution for one chlorine atom in 2-(R,R??-amino)-4,6-dichloro-1,3,5-triazines with a hydroxide ion were elaborated. Spectral and calculation methods showed that the products formed are in the lactam form, i.e., have the structure of 4-chloro-6-(R,R??-amino)-1,3,5-triazin-2(1H)-ones.     

Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives

An efficient route allowing the synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives by reaction of ethyl cyanoacetimidate, ethyl ethoxycarbonylacetimidate and related acetamidines with diethyl ethoxymeth-ylenemalonate (EMME) is reported. The formation of dienamino derivatives as intermediates and their heterocyclization to the 2(1H)-pyridone derivatives is described.     

Diazotization of 6-amino-2-phenyl-7-chloro-2H-benzotriazole-4-carboxylic acid and transformations of the resulting diazo compounds

6-Amino-2-phenyl-7-chloro-2H-benzotriazole-4-carboxylic acid was prepared by oxidation of 2,5-diamino-4-chloro-2-phenylazobenzoic acid, and its diazotization and subsequent transformations of the diazo compounds were studied. 7-Hydroxy-2-phenyl-2H-benzotriazole-4-carboxylic acid was prepared.Translated from Zhurnal Obshchei Khimii, Vol. 74, No. 11, 2004, pp. 1894–1897.Original Russian Text Copyright © 2004 by Artamonov, Perevalov.This revised version was published online in April 2005 with a corrected cover date.     

Synthesis and Structure of [Er4（μ3—OH）4（Hpro）4（Pro）2（H2O）7]（ClO4）6.7H2O

1 INTRODUCTION The design and synthesis of polynuclear com- plexes have attracted chemists?attention in the contemporary chemistry, since their clusters maybe lead to novel materials with magnetic, optical, electronic and catalytic properties of the constituent metals[1～3]. It is also prevalently interesting to synthesize high-nuclearity metal complexes for their nanoscopic dimensions[3, 4]. Spectroscopic properties of the lanthanides are widely used in the study of biological systems. …     

4-氯-6-新戊酰胺基-7-甲氧基喹唑啉的合成

近年来研究发现,喹唑啉类化合物具有良好的医药和农药生物活性,是化学界和生物学界研究的热点.医药方面,喹唑啉类化合物早期应用主要为抗疟药[1],但近年来研究热点转换为其在抗肿瘤方面[2-3]和治疗白血病方面[4-5]的应用,并且,喹唑啉类化合物作为α- 受体阻滞剂,在心血管疾病的防治中也占据重要的地位[6-7].当前的热门抗癌药吉非替尼(gefitinib)[8]就是喹唑啉类化合物广阔发展前景的一个缩影.     

4-氯-6-甲氧基-7-(N-甲基-4-哌啶甲氧基)喹唑啉的合成

凡德他尼(vandetanib)是由阿斯利康公司研发的口服小分子多靶点酪酸激酶抑制剂,可同时作用于肿瘤细胞EGFR、VEGFR和RET酪氨酸激酶[1,2],2006年1月获欧洲罕见病药品委员会(COMP)批准推荐,用于治疗髓甲状腺癌、乳腺癌、骨髓瘤等[3].     

New 4-quinaldinol derivatives XVII. 2-Methyl-3-(3-chloro-2-buten-1-yl)-4-hydroxyquinoline-6-carboxylic acid and some of its transformations

1-(2-Methyl-4-hydroxy-6-carboxy-3-quinolinyl)-3-butanone and 1-(2-methyl-4-chloro-6-carboxy-3-quinolinyl)-3-butanone were obtained by the acid hydrolysis of 2-methyl-3-(3-chloro-2-buten-1-yl)-4-hydroxy(chloro)quinoline-6-carboxylic acids and their esters.See [6] for communication XVI.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 12, pp. 1681–1682, December, 1971.     

Synthesis of 6-nitro-8-chloro-2,3-dieydro-4(1H)-quinolone

6-Nitro-8-chloro-2,3-dihydro-4(1H)-quinolone and its dehydrogenation product-6-nitro-8-chloro-4-hydroxyquinoline — were isolated in the cyclization of N-(2-chloro-4-nitrophenyl--alanine in polyphosphoric acid.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 7, pp. 954–956, July, 1978.     

Synthesis of 5-alkyl(aryl)sulfanyl-4-chloro-3-trichloromethyl-1,2-thiazoles and 5-Alkyl(aryl)sulfanyl-4-chloro-1,2-thiazole-3-carboxylic acids

Butane-, phenylmethane-, and benzenethiols reacted with 4,5-dichloro-3-trichloromethyl-1,2-thiazole in the presence of sodium ethoxide to give the corresponding 5-alkyl(aryl)sulfanyl-4-chloro-3-trichloromethyl-1,2-thiazoles. The reaction of 4,5-dichloro-1,2-thiazole-3-carboxylic acid with the same thiols under similar conditions resulted in the formation of sodium 4,5-dichloro-1,2-thiazole-3-carboxylate, while in the presence of pyridine 5-alkyl(aryl)sulfanyl-4-chloro-1,2-thiazole-3-carboxylic acids were obtained.     

(6R,7R)-7-氨基-3-[2-(4-甲基-5-噻唑)乙烯基]-8-氧代-5-硫-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸的合成

以1-磺丁基-3-甲基咪唑硫酸氢盐离子液体(b)为反应介质,7-氨基头孢烷酸(7-ACA,2)为原料,与4-甲基-5-甲酰基噻唑经缩合反应制得(6R,7R)-7-氨基-3-[2-(4-甲基-5-噻唑)乙烯基]-8-氧代-5-硫-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸(7-ATCA,1),其结构经1H NMR,13C NMR和IR表征。考察了离子液体及其用量,原料摩尔比r[n(4-甲基-5-甲酰基噻唑)∶n(2)],反应温度和反应时间对1收率的影响。在最佳反应条件[b为反应介质,b用量为20 m L,r=1.3,于65℃反应5 h]下,1收率可达90%以上。     

3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲酸的合成

以2,3-二氯吡啶为起始原料,通过水合肼亲核取代、马来酸二乙酯环合制得2-(3-氯-2-吡啶基)-5-氧-3-吡唑烷甲酸乙酯(5);5经苯磺酰氯酯化、溴化氢溴化制得3-溴-1-(3-氯-2-吡啶基)-4,5-二氢-1H-吡唑-5-甲酸乙酯(7);7经脱氢、水解合成了用于制备氯虫酰胺的关键中间体--3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲酸,总收率39.5%,其结构经~1H NMR和MS确证.     

吡啶与GCLE碘取代物在不同溶剂中亲核取代反应动力学研究

以7-苯乙酰氨基-3-氯甲基头孢烷烯酸对甲氧基苄酯（GCLE）和吡啶为原料合成头孢他啶中间体7-苯乙酰氨基-3-吡啶甲基头孢-4-羧酸对甲氧苄酯,用高效液相色谱仪监测了吡啶与GCLE碘取代物在二氯甲烷、丙酮、四氢呋喃、乙酸乙酯和DMF混合液中的亲核取代反应,反应的动力学行为可用SN2机理来解释。在一定的溶剂中不同温度的速率常数可用Arrhenius方程很好的关联。根据Arrhenius方程求得了指前因子,进一步讨论了该反应的溶剂效应,得出在不同溶剂中亲核取代反应顺序为：乙酸乙酯-DMF混合液＞二氯甲烷＞四氢呋喃＞丙酮。     

Synthesis and Crystal Structure of the Binuclear Complex [Pr2(C10H8N2O4)2(C10H9N2O4)2(H2O)4]·3H2O·C6H6

The binuclear praseodymium(III) complex with N‐(1‐carboxyethylidene)‐salicylhydrazide (C₁₀H₁₀N₂O₄, H₂L) was prepared in H₂O‐C₂H₅OH mixed solution, and the crystal structure of [Pr₂L₂(HL)₂(H₂O)₄]·3H₂O·C₆H₆ was determined by X‐ray single crystal diffraction. The crystal complex crystallizes in the triclinic system with space group P‐1, and in the structure each Pr atom is 9‐coordinated by carboxyl O and acyl O and azomethine N atoms of two tridentate ligands to form two stable five‐membered rings sharing one side in keto‐mode and two water molecules. The coordination polyhedron around Pr³⁺ was described as a monocapped square antiprism geometry. In an individual molecule, four tridentate ligands were coordinated by two negative univalent (HL) and two bivalent forms (L) respectively. Two negative univalent ligands were coordinated via μ₂‐bridging mode.     

6-取代苯氧基-7-氯-4-羟基-3-喹啉羧酸乙酯的合成及抗球虫活性研究

设计并合成了10个新的6-取代苯氧基-7-氯-4-羟基-3-喹啉羧酸乙酯类化合物; 合成路线短, 产率高, 原料易得, 易实现工业化; 所有化合物的结构均经¹H NMR, MS, IR和元素分析所证实; 并选择了其中7个化合物进行抗球虫活性实验, 结果表明: 其中4个6-取代苯氧基-7-氯-4-羟基-3-喹啉羧酸乙酯化合物具有抗球虫效果, 并有可能作为抗球虫药物使用.     

基于2-(4-二羟基硼烷)苯基喹啉-4-羧酸的二硼酸化合物的合成

以4-溴苯乙酮、靛红及常见试剂为起始原料,通过Pfitzinger reaction、羧基酯化、钯催化、水解等反应合成2-(4-二羟基硼烷)苯基喹啉-4-羧酸(PBAQA).二胺化合物经二碳酸二叔丁酯单保护、酰胺缩合、盐酸脱保护基,再与另一端苯基硼酸化合物酰胺缩合,合成了3个含有PBAQA结构的二硼酸新化合物,考察了溶剂选择、反应温度、活化反应时间以及反应中羧基化合物与1,3-二环己基碳化二亚胺(DCC)和1-羟基苯并三唑(HOBT)物质的量之比对二硼酸类化合物收率的影响.通过IR、~1H NMR、~(13)C NMR、HRMS对新化合物的结构进行表征.结果表明最佳反应条件为以N,N-二甲基甲酰胺(DMF)作溶剂,反应温度20℃,活化反应60 min,反应中羧基化合物与DCC和HOBT的物质的量之比在1∶20∶20的条件下,收率可达82%,纯度90%.该合成路线具有操作步骤简便,经济适用,副产物少易于纯化等特点,对二硼酸化合物衍生化研究具有重要实用和经济价值.